Attached files
file | filename |
---|---|
8-K - FORM 8-K - IDEX CORP /DE/ | c64660e8vk.htm |
EX-10.1 - EX-10.1 - IDEX CORP /DE/ | c64660exv10w1.htm |
EX-99.2 - EX-99.2 - IDEX CORP /DE/ | c64660exv99w2.htm |
EXHIBIT 99.1
IDEX Enters Into Definitive Agreement to Acquire CVI
Lake Forest, IL May 11, 2011 IDEX Corporation (NYSE: IEX) announced today that it has entered
into a definitive agreement to acquire CVI Melles Griot (CVI), from Norwest Equity Partners
(Norwest), a leading middle market equity investment firm. CVI is a global leader in the design
and manufacture of precision photonic solutions used in the Life Sciences, Research, Semiconductor,
Security and Defense markets.
CVIs innovative products include specialty lasers and light sources, electro-optical components,
opto-mechanical assemblies, including aspheric lenses, laser mirrors, interference filters and
polarizers.
CVI produces critical enabling products for demanding applications such as spectroscopy, cytometry,
remote sensing, target designation and interferometry.
Headquartered in Albuquerque, New Mexico, with manufacturing sites located on three continents,
CVI has annual revenues of approximately $185 million. CVI will operate within IDEXs Health and
Science Technologies segment as a key addition to the optics and photonics platform. With cash
consideration of approximately $400 million, CVI is expected to be accretive to IDEXs earnings
within
the first full year after acquisition.
Commenting on the acquisition, IDEX Chairman and Chief Executive Officer Larry Kingsley stated, We
are thrilled with the opportunity to add CVI to IDEX as the cornerstone to our rapidly expanding
optics and photonics platform. CVI is a true leader in the field of high precision optical
devices, combining leading edge products, top notch design and manufacturing capabilities with a
robust management team and distribution channels that are the envy of the industry. CVIs
catalogue and website are industry standards utilized by photonics engineers and scientists around
the globe when seeking solutions to their most demanding photonics challenges. CVI will now join
ATFilms, acquired earlier this year, and Semrock, acquired in 2008 as part of our optics and
photonics platform. We look forward to significant collaboration in key areas of product design and
production capabilities as we realize strategic selling and operating synergies. We believe the CVI
Melles Griot group, Semrock and ATFilms have precisely the type of enabling technology which binds
them to their customer and aligns well with IDEXs growth plans and operating model. Speaking on
behalf of CVI and Norwest, CVIs Chief Executive Officer, Stuart Schoenmann said, We are truly
excited to see CVI become a part of the IDEX family. IDEX has demonstrated a strong commitment to
its Life Sciences business segment and a sustained focus on growing the optics and photonics
platform. We are proud to become an integral part of this expansion, and we are very pleased with
the opportunity to collaborate with market leaders such as Semrock and ATFilms.
The transaction is subject to regulatory approval and other customary conditions and is expected to
close within 30 to 45 days of todays date.
IDEX management will host a conference call to discuss this transaction on Wednesday, May 11 at
12:00 p.m. Central Time. IDEX invites interested investors to listen to the live webcast and view
the related presentation slides, which will be available on its Web site: www.idexcorp.com. To hear
the live call, log on to the site several minutes before the discussion begins. After clicking on
the presentation icon, follow the instructions to ensure your system is set up for the event, or
download the correct applications at no charge.
The U.S. dial-in number is 800.831.6965; the international dial-in number is 706.758.1748; with
conference ID #66425186. If you are unable to participate on the live call, a replay will be
available through Midnight Eastern, June 11, 2011 by dialing 800.642.1687 or 706.645.9291 or log on
to www.idexcorp.com
About IDEX
IDEX Corporation is an applied solutions company specializing in fluid and metering technologies,
health and science technologies, dispensing equipment, and fire, safety and other diversified
products built to its customers exacting specifications. Its products are sold in niche markets to
a wide range of industries throughout the world. IDEX shares are traded on the New York Stock
Exchange and Chicago Stock Exchange under the symbol IEX.
For further information on IDEX Corporation and its business units, visit the companys Web site at
www.idexcorp.com.